52% of out population believe this something that makes them proud to be british – it means trusted high quality free healthcare - in living memory 1948 people, even children, died because their families couldn't pay - shocking and barbaric but true and not that long ago in relative terms.
Today we face a new challenge rising expectations, the burden of disease, increases in the unit cost of care ad the triumph of living longer = a predicted 22bn 3 gaps health and wellbeing care and quality funding and efficiency.
The future of the NHS depends on closing these gaps which means fundamental change is needed
Innovators Early Adoptors Early Majority Late Majority Laggards
People demanding proof – LM and L
To explain what we are doing I want to introduce you to a few people around the UK
½ million in uk – almost 1 in a 100 people
Cardiovascular (heart and circulatory) disease causes more than a quarter (27 per cent) of all deaths in the UK, or around 155,000 deaths each year - an average of 425 people each day or one every three minutes. Around 41,000 people under the age of 75 in the UK die from CVD each year. There are an estimated 7 million people living with cardiovascular disease in the UK – 3.5 million men and 3.5 million women. An ageing and growing population and improved survival rates from cardiovascular events could see numbers rise still further. The economic burden of CVD, including indirect costs from premature death and disability, is estimated to be over £15 billion each year in the UK. Healthcare costs alone are estimated at up to £11 billion.
Between 12% and 18% of all expenditure on long-term conditions is linked to poor mental health and wellbeing at least £1 in every £8 spent on long-term conditions.
70% of all MH starts before the age of 24 And affects 1 in 4 at some stage in life
Wearables & Apps to Support Self Care
Director of Digital & Multi-channel Development
Late Majority Laggards
People demanding proof
• Privacy, Accessibility, Technical
• Reliability of content used
• Algorithm/ calculations
• Usability best practiceStage 2
Stage 3 Impact / value:
• Clinical safety
• Reach: usage, access
o Cost saving
o Patient factors
+ some external validation
Business case for